PMC’s Pharmacogenomics Working Group convenes members with interest or expertise in issues related to pharmacogenomic testing. The group guides PMC’s efforts in pharmacogenomics and its related engagements with FDA, clinical guidelines developers, and other stakeholders.
PMC members shape and advance the future of personalized medicine.
Join Today